| Takeda Pharma AG - Elvanse 50 mg, Hartkapseln | | 63023 | | 02 | | Elvanse 50 mg | | Hartkapseln | | N06BA12 | | Lisdexamfetamine | | 27.03.2014 | | |
| | Composition | | lisdexamfetamini dimesilas 50 mg corresp. dexamfetaminum 14.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 133, E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.2699 mg. | | Packungsbestandteile | | Capsules | | | | | | | | Active Agent | Dose |
|---|
| Lisdexamfetamini Dimesilas | 50 mg correspond Dexamfetaminum 14.8 mg |
| | BAG: Active Agent | Dose |
|---|
| Lisdexamfetamini Dimesilas | 50 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Nigrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 133 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Magnesii Stearas | | | | Propylenglycol | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 30 Capsule(s) | 99.69 | 124.85 | A+ | SL | No |
|
|
